| Followers | 27 |
| Posts | 2319 |
| Boards Moderated | 0 |
| Alias Born | 01/03/2012 |
Saturday, March 03, 2012 5:59:06 PM
You missed the part where I'm right :p
Again, I don't think marketing experts would announce their new product by drawing your attention away from it. It appears to me that the spyder image at the bottom of that page and the website to which it links are the only places Atrinsic references it. If that qualifies as an announcement to them, then it clearly shows they don't believe Spyder to be a significant new tool to offer their affiliates. Since I believe they'll want to market this new capability (because, why wouldn't they), I think they'll make it more prominent within their presentation. I'm comfortable agreeing to disagree if you don't share my view because it doesn't change my opinion that this so-called delay is a non-issue.
Again, I don't think marketing experts would announce their new product by drawing your attention away from it. It appears to me that the spyder image at the bottom of that page and the website to which it links are the only places Atrinsic references it. If that qualifies as an announcement to them, then it clearly shows they don't believe Spyder to be a significant new tool to offer their affiliates. Since I believe they'll want to market this new capability (because, why wouldn't they), I think they'll make it more prominent within their presentation. I'm comfortable agreeing to disagree if you don't share my view because it doesn't change my opinion that this so-called delay is a non-issue.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
